Sheela Foam is looking at a valuation of $400-500 mn; will dilute 15% stake in offer for sale
Anchor investors cannot sell their shares for 30 days from the date of allotment, while IPO investors can sell them on listing day
Shareholders invited to deposit all or part of their holding in demat form in escrow account by Aug 22
In 2016, six of the twelve issues that hit the market have seen retail investors bidding for more than three times the shares on offer
The share of Ujjivan Financial Services, which made its stock market debut in May, is trading about two times higher than IPO price
The period has seen more than half of the 11 newly-listed stocks trading at a higher premium over the issue price
It garners about 15% revenue from its consumer durables business
The firm, promoted by Ajit Isaac and Thomas Cook (India), has fixed a price band of Rs 310-317 a share with Rs 10 face value
Four of the six bankers shortlisted for the Rs 16,000-crore Vodafone IPO - Bank of America Merrill Lynch, UBS, Deutsche Bank and HSBC - are foreign names
RBL Bank, Mahanagar Gas, GVR Infra Projects, Larsen and Toubro Infotech are some of the firms going public
Sources said number to be less than 10, compared with 14 in 2012
British Gas India Pvt Ltd and state-owned GAIL (India) Ltd will sell 12.5% each in the IPO
Exchange's initial share-sale programme expected to hit market this financial year
Rs 750-cr IPO fails to garner mandatory institutional participation
Continued investments in facilities, products and branding will keep profitability
Thyrocare Technologies to be listed on BSE and NSE in seven working days
The medical diagnostics company's Rs 480-crore IPO closes on Friday
Dr Lal Pathlabs, which came out with its IPO at Rs 550 per share, was listed at a 30% premium at Rs 720 and touched a high of Rs 1,045 a few weeks ago
Given the strong financials and track record, long-term investors could consider the offer